NCT Number: NCT06706193
HXLPE Vs CPE Cups Under 50 Years
This randomized controlled trial evaluated the long-term wear of cemented highly cross-linked polyethylene (HXLPE) versus conventional polyethylene (CPE) acetabular cups in patients under 50 years undergoing primary total hip arthroplasty (THA).
All surgeries were performed at Radboud University Medical Center by three surgeons using a posterolateral approach. Acetabular components included either highly cross-linked polyethylene (HXLPE) cups (X3 RimFit) or conventional polyethylene (CPE) cups (Exeter Contemporary Flanged). Both were implanted with bone cement, and femoral components consisted of Exeter V40 stems with 28 mm cobalt-chromium heads. Impaction bone grafting (IBG) was routinely used, with mesh applied in cases of acetabular bone defects.
Radiographs were taken preoperatively and at 10-year follow-up using standardized protocols. Polyethylene wear was assessed with PolyWare software, creating 3D models from baseline and 10-year radiographs to calculate linear and volumetric wear. Cup inclination and osteolysis were evaluated in three acetabular zones (DeLee and Charnley classification).
Looking for future studies?
Notify MeKey information
Conditions
Age range
16 year–50 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 4
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- primary THA
- age under 50 years
Exclusion criteria
- THA due to an oncological condition
Treatment and study plan
Total hip arthroplasty using HXLPE
ProcedurePrimary outcomes
-
Linear wear (mm/y)
Time frame: 10 years
-
Volumetric wear (mm3/y)
Time frame: 10 years
Secondary outcomes
-
Cup survival (%)
Time frame: 10 years
Sponsors and collaborators
Lead sponsor
Radboud University Medical Center
Other
Registry information
Official study title
Wear Resistance of Highly Crosslinked Cemented Polyethylene Cups in Young Patients
Important dates
- Study start
- 2010
- Primary completion
- 2023
- Study completion
- 2023
- First posted
- Nov 26, 2024
- Registry last updated
- Nov 26, 2024
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Effect of Single vs Multiple Prophylactic Antibiotic Doses on PJI Following Primary THA in Patients With OA
NCT05530551
Arthritis, Joint Diseases
Aabenraa, Denmark
View Trial DetailsA Prospective Multicenter Longitudinal Cohort Study of the Mymobility Platform
NCT03737149
Arthritis, Bronchial Diseases
Fremont, California, United States
View Trial DetailsPericapsular Nerve Group Block Added to Intra-articular Corticosteroid Injection in the Treatment of Hip Pain
NCT07427238
Arthritis, Hip Pain Chronic
Ankara, Turkey (Türkiye)
View Trial DetailsDevelopment of an Osteoarthritis (OA) Care Plan to Improve Process and Quality of OA Treatment Decisions
NCT03102580
Arthritis, Joint Diseases
Chicago, Illinois, United States
View Trial Details